What is Olema Pharmaceuticals, Inc. Common Stock's Market Cap?

Olema Pharmaceuticals, Inc. Common Stock's Market Cap is $973.6M, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Olema Pharmaceuticals, Inc. Common Stock's Enterprise Value is $512.5M, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Olema Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Olema Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$204.6M, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's EBITDA?

Olema Pharmaceuticals, Inc. Common Stock's EBITDA is -$220.7M, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Olema Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.34, based on as-reported figures from SEC (XBRL) filings.

What is Olema Pharmaceuticals, Inc. Common Stock's Net Debt?

Olema Pharmaceuticals, Inc. Common Stock's Net Debt is -$461.1M, based on as-reported figures from SEC (XBRL) filings.

Olema Pharmaceuticals, Inc. Common Stock (OLMA) Financial Statements

Olema Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00T5JMRV1

XNAS · usd

11.13▲ 0.14 (1.30%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close10.99

Day's Range10.46 – 11.06

52-Week Range6.65 – 36.26

Volume735.1K

Avg Volume910.2K

Share Statistics

Shares Outstanding

Employees131

ExchangeXNAS

Listed2020-11-19

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Olema Pharmaceuticals, Inc. Common Stock (OLMA)

What is Olema Pharmaceuticals, Inc. Common Stock's Market Cap?: Olema Pharmaceuticals, Inc. Common Stock's Market Cap is $973.6M, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Olema Pharmaceuticals, Inc. Common Stock's Enterprise Value is $512.5M, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Olema Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Olema Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$204.6M, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's EBITDA?: Olema Pharmaceuticals, Inc. Common Stock's EBITDA is -$220.7M, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Olema Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.34, based on as-reported figures from SEC (XBRL) filings.
What is Olema Pharmaceuticals, Inc. Common Stock's Net Debt?: Olema Pharmaceuticals, Inc. Common Stock's Net Debt is -$461.1M, based on as-reported figures from SEC (XBRL) filings.